|
ZFP82 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.968400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.004500E-03 |
| Normal-vs-Stage2 |
1.365210E-04 |
| Normal-vs-Stage3 |
1.116350E-03 |
| Normal-vs-Stage4 |
1.420170E-02 |
| Stage1-vs-Stage2 |
1.711010E-01 |
| Stage1-vs-Stage3 |
4.402600E-01 |
| Stage1-vs-Stage4 |
7.548600E-01 |
| Stage2-vs-Stage3 |
7.638800E-01 |
| Stage2-vs-Stage4 |
6.250800E-01 |
| Stage3-vs-Stage4 |
8.567200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.042190E-04 |
| Normal-vs-AfricanAmerican |
1.331680E-02 |
| Normal-vs-Asian |
1.038040E-01 |
| Caucasian-vs-AfricanAmerican |
1.751780E-01 |
| Caucasian-vs-Asian |
7.827600E-01 |
| AfricanAmerican-vs-Asian |
8.470400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05770000002892E-06 |
| Normal-vs-Female |
1.150750E-01 |
| Male-vs-Female |
2.104000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.087800E-02 |
| Normal-vs-Extreme_Weight |
2.42480000001155E-06 |
| Normal-vs-Obese |
1.762020E-03 |
| Normal-vs-Extreme_Obese |
2.757300E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.501800E-02 |
| Normal_Weight-vs-Obese |
3.491600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.560040E-01 |
| Extreme_Weight-vs-Obese |
1.012220E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.069200E-01 |
| Obese-vs-Extreme_Obese |
2.099000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.339900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.457200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.78170000000511E-05 |
| Normal-vs-Age(81-100Yrs) |
5.606400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.543200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.255400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.369000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.340100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.739230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.195200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.11829999999802E-05 |
| Normal-VS-Type2 PRCC |
2.177000E-03 |
| Normal-VS-KIRP CIMP |
2.584000E-03 |
| Normal-VS-Unclassified PRCC |
3.057500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.663200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.214800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.687000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.124800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.748000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.006200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95075999999128E-05 |
| Normal-vs-N1 |
9.033600E-02 |
| Normal-vs-N2 |
7.396100E-04 |
| N0-vs-N1 |
2.865400E-01 |
| N0-vs-N2 |
6.626300E-02 |
| N1-vs-N2 |
1.173760E-01 |
|
|
